
Equities hold gains as the rate path narrows into year-end
Investors are re-pricing the odds of further easing, and index leadership is quietly rotating away from the largest technology names.
Market data temporarily unavailable.
Stay informed with market data, stock insights, currency information, business coverage, health developments and useful tools — all in one place.

US benchmark indices and bitcoin at a glance.
Market data temporarily unavailable. Please try again shortly.
Market data temporarily unavailable. Please try again shortly.
Major US dollar pairs, refreshed whenever the exchange-rate source is connected.
Exchange rate data temporarily unavailable. Please try again shortly.
Convert between major currencies using the configured rate source.
Reporting and analysis across markets, business and health.

Investors are re-pricing the odds of further easing, and index leadership is quietly rotating away from the largest technology names.

Sep 15, 2026

Sep 14, 2026

Sep 14, 2026

Sep 13, 2026
Market news, economy, corporate developments and business coverage.

Investors are re-pricing the odds of further easing, and index leadership is quietly rotating away from the largest technology names.

Labor data and consumer spending are pointing in different directions, leaving forecasters with a wide band of plausible outcomes.

Investment-grade supply has been met with steady demand, keeping spreads contained despite the volume.
Screened lists of US-listed equities across activity, momentum and income.
AAPL
Apple Inc.
$214.32
Apple Inc. share price increased 1.14 percentVolume 54.2M
NVDA
NVIDIA Corporation
$121.08
NVIDIA Corporation share price increased 4.18 percentVolume 312.7M
TSLA
Tesla, Inc.
$182.44
Tesla, Inc. share price decreased 3.25 percentVolume 98.1M
MSFT
Microsoft Corporation
$428.91
Microsoft Corporation share price increased 0.29 percentVolume 18.9M
AMZN
Amazon.com, Inc.
$186.70
Amazon.com, Inc. share price decreased 1.03 percentVolume 41.3M
INTC
Intel Corporation
$30.18
Intel Corporation share price decreased 4.49 percentVolume 72.5M
Medical research, healthcare systems, health technology and pharmaceuticals.

Adaptive protocols are shortening timelines for early-phase research, but regulators are asking sharper questions about endpoints.

Health networks are consolidating records platforms to support decision support tools, with mixed results for frontline staff.
Chronological feed across all sections.

Investors are re-pricing the odds of further easing, and index leadership is quietly rotating away from the largest technology names.

Relative rate differentials continue to drive currency markets, with the yen and euro the most sensitive to policy commentary.

Capital spending commitments from large buyers are filtering through supplier guidance and changing how analysts model the cycle.

Adaptive protocols are shortening timelines for early-phase research, but regulators are asking sharper questions about endpoints.

Health networks are consolidating records platforms to support decision support tools, with mixed results for frontline staff.

Labor data and consumer spending are pointing in different directions, leaving forecasters with a wide band of plausible outcomes.
Free calculators for investing, currency and everyday health questions.
Convert between major currency pairs using the configured exchange-rate source.
Open toolProject growth of an initial balance with recurring contributions over time.
Open toolEstimate an end balance from a lump sum, monthly savings and expected return.
Open toolCalculate the compound annual growth rate between a starting and ending value.
Open toolWork out annual dividend income and yield on cost for a holding.
Open toolCalculate body mass index in metric or US units, with general reference ranges.
Open toolQuestions, story tips, corrections or partnership ideas — send them to the desk.